Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pfizer, Lilly, Sanofi, Amgen And Others Implicated In Indian Clinical Trial Compensation Investigation; Are Ethics Committees To Blame?

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - India's Health Ministry is calling on multinational drug companies operating in India - including Pfizer Inc., Eli Lilly & Co., Amgen Inc., Bristol-Myers Squibb Co., Boehringer Ingelheim GMBH, Sanofi, and Quintiles Transnational Corp. - to explain why they have not provided compensation to the families of 26 patients who died during clinical trials in the last year. A recent health ministry investigation found that out of 671 cases of reported deaths allegedly involving clinical trials - and involving as many as 44 companies - only three were compensated, but companies suggest regulators should look to India's ethics committees for answers
Advertisement

Related Content

Patient Safety First: Indian Regulator Takes Steps To Tighten Grip Over Site Inspections, Ensure Data Credibility
Patient Safety First: Indian Regulator Takes Steps To Tighten Grip Over Site Inspections, Ensure Data Credibility
Clinical Research Is Booming In India But Are There Enough IRBs?
Advertisement
UsernamePublicRestriction

Register

SC078016

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel